Responses
Ovarian cancer
2022-RA-1094-ESGO Implementation of a tri-modal prehabilitation intervention – KORE-INNOVATION: the first prospective clinical trial to assess a perioperative pathway to reduce postoperative complications in ovarian cancer patients
Compose a Response to This Article
Other responses
No responses have been published for this article.